Muscling in on salbutamol

The Lancet

Volumn 340, Issue 8832, 1992, Pages 1407-

  Palmer, J B D ^a   Shepherd, G L ^b   Cifelli, A T ^b   Myles, PaulS ^c   Weeks, AnthonyM ^c  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; SALBUTAMOL; SALBUTAMOL SULFATE; DELAYED ACTION PREPARATIONS;

ASTHMA; ATHLETE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LETTER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ANIMAL; DELAYED RELEASE FORMULATION; DOPING; DRUG EFFECT; MUSCLE; NOTE;

ALBUTEROL; ANIMAL; ASTHMA; CLENBUTEROL; DELAYED-ACTION PREPARATIONS; DOPING IN SPORTS; HUMAN; MUSCLES;

EID: 0027112998     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)92591-3     Document Type: Letter

References (11)

1. Clinical pharmacokinetics of β-agonists
2. 2-adrenoceptor activation
3. Single dose and steady state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release m patient with bronchial asthma
4. Metabolic studies of salbutamol-3H: a new bronchodilator, in rat, rabbit, dog and man
5. Human pharmacologic and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator
6. The metabolism of salbutamol in man
7. Is salbutamol ergogenic? The effects of salbutamol on physical performance in high-performance nonasthmatic athletes
8. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue
9. Effect of salbutamol on skeletal muscle functional capacity in man
10. Impact of malnutrition and its therapy on liver transplantation
11. Heart transplant nutrition programs: a national survey